American Oriental Bioengineering Inc (AOB) financial statements (2020 and earlier)

Company profile

Business Address NO, 4018 JINTIAN ROAD, ANLIAN PLAZA
FUTIAN, DISTRICT SHENZHEN, 518026
State of Incorp. CO
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
12/31/2011
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7
Cash and cash equivalents7
Receivables46
Inventory, net of allowances, customer advances and progress billings21
Inventory21
Prepaid expense0
Advances on inventory purchases10
Other current assets1
Other undisclosed current assets11
Total current assets:95
Noncurrent Assets
Property, plant and equipment171
Long-term investments and receivables3
Long-term investments3
Intangible assets, net (including goodwill)145
Intangible assets, net (excluding goodwill)145
Deferred costs0
Other undisclosed noncurrent assets31
Total noncurrent assets:351
TOTAL ASSETS:446
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28
Accounts payable11
Accrued liabilities16
Taxes payable1
Debt7
Other undisclosed current liabilities71
Total current liabilities:106
Noncurrent Liabilities
Long-term debt and lease obligation1
Long-term debt, excluding current maturities1
Liabilities, other than long-term debt12
Deferred tax liabilities, net12
Total noncurrent liabilities:13
Total liabilities:119
Stockholders' equity
Stockholders' equity attributable to parent, including:328
Preferred stock0
Common stock0
Treasury stock, value(1)
Additional paid in capital178
Accumulated other comprehensive income72
Retained earnings78
Other undisclosed stockholders' equity attributable to parent0
Total stockholders' equity:328
TOTAL LIABILITIES AND EQUITY:446

Income statement (P&L) ($ in millions)

12/31/2012
12/31/2011
Revenues145
Cost of revenue(101)
Gross profit:44
Operating expenses(131)
Operating loss:(86)
Nonoperating income
(Other Nonoperating income)
0
Interest and debt expense36
Loss from continuing operations before equity method investments, income taxes:(50)
Loss from equity method investments(3)
Other undisclosed loss from continuing operations before income taxes(5)
Loss from continuing operations before income taxes:(58)
Income tax expense(2)
Net loss:(60)
Net income attributable to noncontrolling interest0
Net loss available to common stockholders, diluted:(60)

Comprehensive Income ($ in millions)

12/31/2012
12/31/2011
Net loss:(60)
Comprehensive loss:(60)
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)
Other undisclosed comprehensive income, net of tax, attributable to parent4
Comprehensive loss, net of tax, attributable to parent:(56)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: